<table id="_Refid_2f45bbc2-8bdf-4eb4-8225-5846724b4" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9: Results of Drug Interaction Studies with Didanosine: Effects of Coadministered Drug on Didanosine Plasma AUC and C<sub>max</sub> Values</caption>
<col width="20%"></col>
<col width="20%"></col>
<col width="20%"></col>
<col width="20%"></col>
<col width="20%"></col>
<tbody>
<tr>
<td align="center" colspan="3" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph> </paragraph>
</td>
<td align="center" colspan="2" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">% Change of Didanosine </content>
<br/>
<content stylecode="bold">Pharmacokinetic Parameters</content>
<footnote id="_Refid-cdfff5aa-1920-439d-b80d-1899b56cb">The 90% confidence intervals for the percent change in the pharmacokinetic parameter are displayed.</footnote>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Botrule " valign="bottom">
<paragraph>
<content stylecode="bold">Drug </content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule " valign="bottom">
<paragraph>
<content stylecode="bold">Didanosine Dosage </content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule " valign="bottom">
<paragraph>
<content stylecode="bold">n </content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">AUC of</content>
<br/>
<content stylecode="bold">Didanosine</content>
<br/>
<content stylecode="bold">(90% CI) </content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>
<content stylecode="bold">Cmax of</content>
<br/>
<content stylecode="bold">Didanosine</content>
<br/>
<content stylecode="bold">(90% CI)</content>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">tenofovir</content>,<footnote id="_Refid-1d9f27ac-4715-4e60-bd53-406c9b108">All studies conducted in healthy volunteers at least 60 kg with creatinine clearance of at least 60 mL/min.</footnote>
<footnote id="_Refid-912a4e79-25e1-4e7e-bf62-11c7e5e60">Tenofovir disoproxil fumarate.</footnote> 300 mg once <br/>daily with a light meal<footnote id="_Refid-d1526bdd-d158-454d-863e-7505eff47">373 kcalories, 8.2 grams fat.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>400 mg single dose <br/>fasting 2 hours <br/>before tenofovir </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>26</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↑ 48%<br/>(31, 67%)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↑ 48%<br/>(25, 76%)</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">tenofovir</content>,<footnoteref idref="_Refid-1d9f27ac-4715-4e60-bd53-406c9b108"></footnoteref>
<footnoteref idref="_Refid-912a4e79-25e1-4e7e-bf62-11c7e5e60"></footnoteref> 300 mg once <br/>daily with a light meal<footnoteref idref="_Refid-d1526bdd-d158-454d-863e-7505eff47"></footnoteref>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>400 mg single dose <br/>with tenofovir and a <br/>light meal </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>25</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↑ 60%<br/>(44, 79%)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↑ 64%<br/>(41, 89%)</paragraph>
</td>
</tr>
<tr>
<td align="center" rowspan="3" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">tenofovir</content>,<footnoteref idref="_Refid-1d9f27ac-4715-4e60-bd53-406c9b108"></footnoteref>
<footnoteref idref="_Refid-912a4e79-25e1-4e7e-bf62-11c7e5e60"></footnoteref> 300 mg once <br/>daily with a light meal<footnoteref idref="_Refid-d1526bdd-d158-454d-863e-7505eff47"></footnoteref>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>200 mg single dose <br/>with tenofovir and a <br/>light meal </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>33</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↑ 16%<br/>(6, 27%)<footnote id="_Refid-fefd38b9-76d7-4723-8599-a0cba34c9">Compared with didanosine 250 mg administered alone under fasting conditions.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↓ 12%<br/>(-25, 3%)<footnoteref idref="_Refid-fefd38b9-76d7-4723-8599-a0cba34c9"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>250 mg single dose <br/>with tenofovir and a <br/>light meal </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>33</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↔<br/>(-13, 5%)<footnote id="_Refid-7e0e8c3b-fc07-4549-998b-7eac0fa29">Compared with didanosine 400 mg administered alone under fasting conditions.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↓ 20%<br/>(-32, -7%)<footnoteref idref="_Refid-7e0e8c3b-fc07-4549-998b-7eac0fa29"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>325 mg single dose <br/>with tenofovir and a <br/>light meal </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>33</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↑ 13%<br/>(3, 24%)<footnoteref idref="_Refid-7e0e8c3b-fc07-4549-998b-7eac0fa29"></footnoteref>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↓ 11%<br/>(-24, 4%)<footnoteref idref="_Refid-7e0e8c3b-fc07-4549-998b-7eac0fa29"></footnoteref>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">methadone</content>, chronic maintenance dose</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>400 mg single dose</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>15, 16<footnote id="_Refid-27c824ff-c4ea-48bd-9a4e-0eebbb2cb">Comparisons are made to historical controls (n = 148, pooled from five studies) conducted in healthy subjects. The number of subjects evaluated for AUC and C<sub>max</sub> is 15 and 16, respectively.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↓17%<br/>(-29, -2%)</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>↓16%<br/>(-33, 4%)</paragraph>
</td>
</tr>
<tr>
<td colspan="5" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>↑ Indicates increase. <br/>↓ Indicates decrease. <br/>↔ Indicates no change, or mean increase or decrease of less than 10%. </paragraph>
</td>
</tr>
</tbody>
</table>